The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Bolt Biotherapeutics, Inc.

LOS ANGELES, CA / ACCESSWIRE / September 4, 2024

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. (“Bolt” or “the Company”) (NASDAQ:BOLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities